Mitigating acute chemotherapy-associated adverse events in patients with cancer

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Nature Reviews Clinical Oncology

• Publication date

  2022-10-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41571-022-00685-3PMID 36221000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noise: A Flaw in Human Judgment

  2023cited by this paper
• perspectives of

  2022cited by this paper
• A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis

  2022cited by this paper
• Judgment

  2022cited by this paper
• A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin

  2022cited by this paper
• Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity

  2021cited by this paper
• Metagenomics and chemotherapy‐induced nausea: A roadmap for future research

  2021cited by this paper
• Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.

  2021cited by this paper
• Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?

  2021cited by this paper
• Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era

  2021cited by this paper
• Advances in the Management of Cancer-Associated Thrombosis

  2021cited by this paper
• American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.

  2021cited by this paper
• Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study.

  2021cited by this paper
• Chemotherapy-induced alopecia in African American women: a literature review demonstrates a knowledge gap.

  2021cited by this paper
• Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity

  2021cited by this paper
• Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels

  2020cited by this paper
• An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management.

  2020cited by this paper
• Supportive care in patients with cancer during the COVID-19 pandemic

  2020cited by this paper
• Statins reduce new-onset atrial fibrillation after acute myocardial infarction

  2020cited by this paper
• Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis.

  2020cited by this paper
• Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action

  2020cited by this paper
• The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta‐analysis

  2020cited by this paper
• MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

  2020cited by this paper
• Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines

  2020cited by this paper
• Protective-2 (BPI-2358-106): A Confirmatory Trial to Demonstrate Superiority of the Plinabulin+Pegfilgrastim (Plin/Peg) Combination Versus Standard of Care Pegfilgrastim for the Prevention of Chemotherapy-Induced Neutropenia (CIN) in Breast Cancer (BC) Patients (pts)

  2020cited by this paper
• NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020.

  2020cited by this paper
• Genomic Profiling Identifies Somatic Mutations Predicting Thromboembolic Risk in Patients with Solid Tumors

  2020cited by this paper
• Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines

  2020cited by this paper
• Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends.

  2020cited by this paper
• Population‐level evidence of survival benefits of patient‐reported outcome symptom monitoring software systems in routine cancer care

  2020cited by this paper
• Antiemetics: ASCO Guideline Update.

  2020cited by this paper
• Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

  2020cited by this paper
• Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.

  2020cited by this paper
• Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology.

  2019cited by this paper
• Chemotherapy

  2019cited by this paper
• Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

  2019cited by this paper
• Revisiting the physiology of nausea and vomiting—challenging the paradigm

  2019cited by this paper
• Magic Mouthwash for Oral Mucositis: A Teachable Moment.

  2019cited by this paper
• Rivaroxaban for Thromboprophylaxis in High‐Risk Ambulatory Patients with Cancer

  2019cited by this paper
• Febuxostat administration for the prevention of tumour lysis syndrome: A meta‐analysis

  2019cited by this paper
• Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines.

  2019cited by this paper
• The pathogenesis of mucositis: updated perspectives and emerging targets.

  2019cited by this paper
• Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines—part 1: vitamins, minerals, and nutritional supplements

  2019cited by this paper
• Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

  2019cited by this paper
• Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta‐analysis

  2019cited by this paper
• Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma.

  2019cited by this paper
• Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.

  2018cited by this paper
• Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients

  2018cited by this paper
• Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.

  2018cited by this paper
• Management of Chemotherapy-Induced Alopecia With Scalp Cooling.

  2018cited by this paper
• Value of incorporating newly identified risk factors into risk prediction for chemotherapy‐induced febrile neutropenia

  2018cited by this paper
• Oral Cryotherapy: Prevention of oral mucositis and pain among patients with colorectal cancer undergoing chemotherapy

  2018cited by this paper
• Reporting harms more transparently in trials of cancer drugs

  2018cited by this paper
• A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.

  2018cited by this paper
• Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic Review

  2018cited by this paper
• Mechanisms Underlying Chemotherapy-Associated Mucositis : The Role of Inflammatory Mediators and Potential Therapeutic Targets

  2018cited by this paper
• Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer.

  2018cited by this paper
• Learning from Patients: Reflections on Use of Patient-Reported Outcomes in Lung Cancer Trials.

  2018cited by this paper
• : A Review of the

  2018cited by this paper
• Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.

  2018cited by this paper
• Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).

  2018cited by this paper
• Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models

  2017cited by this paper
• The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK.

  2017cited by this paper
• Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor

  2017cited by this paper
• Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence

  2017cited by this paper
• Predicting neutropenia risk in patients with cancer using electronic data

  2017cited by this paper
• Radiation-Induced Oral Mucositis

  2017cited by this paper
• The postthrombotic syndrome: current evidence and future challenges

  2017cited by this paper
• Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial

  2017cited by this paper
• Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial.

  2017cited by this paper
• Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis

  2017cited by this paper
• Palifermin for oral mucositis after intensive therapy for hematologic cancers

  2017cited by this paper
• Systematic review and meta-analysis.

  2017cited by this paper
• The biology and genetics of curly hair

  2017cited by this paper
• Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.

  2017cited by this paper
• Randomized controlled trial

  2016cited by this paper
• Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

  2016cited by this paper
• Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.

  2016cited by this paper
• Issues on the Use of White Blood Cell Growth Factors in Oncology Practice.

  2016cited by this paper
• Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients

  2016cited by this paper
• A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.

  2016cited by this paper
• Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer

  2016cited by this paper
• 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.

  2016cited by this paper
• Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial.

  2016cited by this paper
• Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysis.

  2016cited by this paper
• Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol

  2016cited by this paper
• Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors With Chemotherapy for Breast Cancer.

  2016cited by this paper
• Changing patterns of chemotherapy relative dose intensity and supportive care for aggressive B-cell non-Hodgkin lymphoma

  2016cited by this paper
• Retrospective study

  2016cited by this paper
• Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

  2016cited by this paper
• Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy.

  2015cited by this paper
• Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use.

  2015cited by this paper
• Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.

  2015cited by this paper
• Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.

  2015cited by this paper
• Prediction of Venous Thromboembolism in Patients with Cancer By the Activated Partial Thromboplastin Time: Results from the Vienna Cancer and Thrombosis Study

  2015cited by this paper
• Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices.

  2015cited by this paper
• A prospectively validated nomogram for predicting the risk of chemotherapy-induced febrile neutropenia: a multicenter study

  2015cited by this paper
• Management of chemotherapy-induced neutropenia: measuring quality, cost, and value.

  2015cited by this paper
• Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

  2015cited by this paper
• Nail toxicities induced by systemic anticancer treatments.

  2015cited by this paper

• Expanding the druggable proteome strategies and innovations in targeted protein degradation

  2026cites this paper
• Size-Transformable Amphiphilic Dendrimer-based Drug Nanomicelles for Enhanced Tumor Penetration in Cancer Chemotherapy.

  2026cites this paper
• Magnetic carbomer microrobots for targeted drug delivery: A model study toward renal cell carcinoma therapy

  2026cites this paper
• Photo-responsive polyprodrug supramolecular assemblies with self-accelerated subcellular delivery for synergistic photochemotherapy.

  2026cites this paper
• Transient absorption spectroscopy: a mechanistic tool for triplet sensitizers and their applications.

  2026cites this paper
• Patient-Perceived Overall Side Effect Bother at and After Cancer Treatment Discontinuation: An Analysis Using Commercial Cancer Trial Data

  2026cites this paper
• Probiotic or synbiotic interventions and chemotherapy-associated diarrhea in cancer patients: a meta-analysis of randomized trials

  2026cites this paper
• Impact of Curcuma longa on Hematopoiesis and Splenic Mass in an Animal Model Undergoing Docetaxel Chemotherapy

  2026cites this paper
• The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment.

  2026cites this paper
• Near-infrared-II/glutathione-dual responsive multifunctional conjugated polymer nanoparticles for synergistic photothermal/chemotherapy of tumors

  2026cites this paper
• Redox-Responsive Multimodal Nanoplatform Based on Porous Silicon Nanoparticles with Copper Silicate Layer for Synergistic Anticancer Therapy.

  2026cites this paper
• Exploiting intracellular oncogenic proteins to release cytotoxins

  2026cites this paper
• Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs.

  2026cites this paper
• Glutathione-depleting photosensitizers for tumor-specific imaging and pyroptosis-driven photodynamic therapy

  2026cites this paper
• Overcoming Chemoresistance via an AIEgen-Based Covalent Organic Framework.

  2026cites this paper
• Engineering tumor microenvironment-responsive nanoparticles for targeted cancer therapy

  2026cites this paper
• Efficacy of a plant-based diet on FOLFOX chemotherapy-induced gastrointestinal toxicity in patients with colorectal cancer: study protocol for a multicentre, stratified, randomised controlled trial.

  2026cites this paper
• Predicting resistance to chemotherapy using chromosomal instability signatures

  2025cites this paper
• Inconsistent and Inaccurate Cancer Clinical Trial Reporting of Venous and Arterial Thrombotic Events: An Urgent Call to Action.

  2025cites this paper
• Mitigation and management of adverse events associated with amivantamab therapy

  2025cites this paper
• Nanoscale Porphyrin-Based Metal–Organic Frameworks for Enhanced Radiotherapy–Radiodynamic Therapy: A Comprehensive Review

  2025cites this paper
• Multifunctional peptide- and natural polymer-based smart biomaterials: Synthetic approaches and cancer treatment applications

  2025cites this paper
• Design and application of multi-rotor aza-BODIPY for enhanced phototherapeutic efficacy

  2025cites this paper
• A photoactivatable nano-liposome containing tripartite therapeutics for photothermal-triggered chemotherapy.

  2025cites this paper
• Harnessing microbial hydrogen for remodeling tumor microenvironment to potentiate collaborative chemo-immunotherapy

  2025cites this paper
• Insights on the differences between two- and three-dimensional culture systems in tumor models (Review)

  2025cites this paper
• Treatment of advanced cervical cancer with Cinobufacini and Paclitaxel–Cisplatin combination: A meta-analysis

  2025cites this paper
• Cathepsin B-Activated Prodrug for Precision Tumor Theranostics.

  2025cites this paper
• Tumor organoids may be more suitable for clinical personalized chemotherapeutic drug screening in lung adenocarcinoma

  2025cites this paper
• Bioimplantable Bifunctional Zinc/Magnesium–Oxygen Battery for Synergistic Gas Therapy and Hypoxia‐Activated Chemotherapy

  2025cites this paper
• Hydrophobic affecting in drug-peptide co-assembly: From supramolecular morphology to targeted delivery.

  2025cites this paper
• Magnetic Fields as Biophysical Modulators of Anticancer Drug Action

  2025cites this paper
• Phenylboronic Acid-Modified and ROS-Responsive Polymeric Nanoparticles for Targeted Anticancer Drug Delivery

  2025cites this paper
• Drug repurposing of natural depsipeptide from Eleftheria terrae isolated via iChip for anti-breast cancer therapy

  2025cites this paper
• Shengbai oral solution for chemotherapy-induced neutropenia and symptom management in non-small cell lung cancer: A multicenter, randomized, open-label trial.

  2025cites this paper
• Feasibility and Safety of Anti-PD1 First-Line Treatment of Classic Hodgkin Lymphoma: Do We See the Full Picture?

  2025cites this paper
• Immunotherapy Rechallenge of Advanced NSCLC with Acquired EGFR T790M Mutation after EGFR-TKI Therapy: A Case Report

  2025cites this paper
• Prevalence and factors associated with chemotherapy-induced adverse events in cancer treatment centers in Amhara national regional state comprehensive referral hospitals, 2024: multicenter prospective follow up study

  2025cites this paper
• Construction of PANoptosis‐Inhibiting Carbonized Polymer Dots via Machine Learning Potential for Mitigating Chemodrug‐Induced Nephrotoxicity

  2025cites this paper
• Capturing durable benefits: interpreting six-year treatment-free survival and restricted mean survival time in CheckMate 227

  2025cites this paper
• Stereotactic Body Radiotherapy Without Systemic Therapy for Oligometastatic Cancer

  2025cites this paper
• An Overview of the Importance of Muscle Health in Oncology: Assessment, Preservation, and Nutritional Recovery Strategies

  2025cites this paper
• Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapy

  2025cites this paper
• Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone-receptor-positive HER2-negative breast cancer: final overall survival analysis of the phase 3 TROPION-Breast01 study.

  2025cites this paper
• Systematic review and meta-analysis of chemotherapy-induced adverse drug reactions among children with cancer in Africa

  2025cites this paper
• An Immune Nanoenhancer Revitalizes Chemotherapeutics to Tailor Tumor‐Derived dsDNA for Anticancer Immunoengineering

  2025cites this paper
• Anti-tumor Effect of Glycopeptides with Different Morphologies

  2025cites this paper
• Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting

  2025cites this paper
• Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury

  2025cites this paper
• The glowing frontier: Carbon dots' journey for customized cancer treatments

  2025cites this paper
• A computer-aided, carrier-free drug delivery system with enhanced cytotoxicity and biocompatibility: A universal model for multifunctional lung cancer therapy.

  2025cites this paper
• Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility in-vitro

  2025cites this paper
• Concerns of Women With Breast Cancer During Their Therapy in Iran: A Qualitative Investigation

  2025cites this paper
• The role of nanotechnologies in diagnostics and treatment of female reproductive system cancer

  2025cites this paper
• Association of ABC Efflux Transporter Genetic Variants and Adverse Drug Reactions and Survival in Patients with Non-Small Lung Cancer

  2025cites this paper
• Pharmacoscintigraphy: Advancing Nanotheranostic Development Through Radionuclide Imaging

  2025cites this paper
• Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events

  2025cites this paper
• 5-Fluorouracil Impairs Transmission of Acetylcholine in the Hippocampus and Induces Cognitive Impairments in Mice.

  2025cites this paper
• Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort

  2025cites this paper
• Near-infrared BODIPY-based theranostic agents for photothermal and combinatory therapy of cancers, where do we stand in year 2025

  2025cites this paper
• Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignancies.

  2025cites this paper
• Incomplete neoadjuvant chemo(radio)therapy negatively impacts pathological response and overall survival in locally advanced esophageal cancer.

  2025cites this paper
• Chitosan/Carbon Quantum Dots/Polyvinylpyrrolidone Nanocarrier for Enhanced Anticancer Efficacy of Doxorubicin

  2025cites this paper
• Recent advances in nanomedicine design strategies for targeting subcellular structures

  2024cites this paper
• Hyaluronic acid-functionalized graphene-based nanohybrids for targeted breast cancer chemo-photothermal therapy.

  2024cites this paper
• Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics

  2024cites this paper
• Synergistic anticancer effect of Pistacia lentiscus essential oils and 5-Fluorouracil co-loaded onto biodegradable nanofibers against melanoma and breast cancer

  2024cites this paper
• Peptide‐Based Supramolecular Therapeutics for Fighting Major Diseases

  2024cites this paper
• Deformable Smart DNA Nanomachine for Synergistic Intracellular Cancer-Related miRNAs Imaging and Chemo-Gene Therapy of Drug-Resistant Tumors.

  2024cites this paper
• Advances and applications of nanoparticles in cancer therapy

  2024cites this paper
• Glutathione-Responsive and Hydrogen Sulfide Self-Generating Nanocages Based on Self-Weaving Technology To Optimize Cancer Immunotherapy.

  2024cites this paper
• Efficacy of acupoint injection of metoclopramide for post-chemotherapy vomiting: A systematic review and meta-analysis

  2024cites this paper
• Engineered oncolytic bacteria for malignant solid tumor treatment

  2024cites this paper
• Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved

  2024cites this paper
• Intelligent gold nanocluster for effective treatment of malignant tumor via tumor-specific photothermal–chemodynamic therapy with AIE guidance

  2024cites this paper
• A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation.

  2024cites this paper
• Zwitterionic targeting nanodrugs prepared from poly(propyleneimine) dendrimers for enhanced anti-tumor therapy

  2024cites this paper
• Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer.

  2024cites this paper
• The evolving landscape of tissue‐agnostic therapies in precision oncology

  2024cites this paper
• Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)

  2024cites this paper
• Reactive oxygen species responsive chitooligosaccharides based nanoplatform for sonodynamic therapy in mammary cancer.

  2024cites this paper
• Dual‐Responsive Nanoreactor Initiates In Situ Generation of Copper Complex for Paraptosis‐Mediated Tumor Chemo‐Immunotherapy

  2024cites this paper
• Efficacy of Filgrastim in Managing Chemotherapy-Induced Febrile Neutropenia in Iraqi Patients with Non-Small Cell Lung Cancer

  2024cites this paper
• Artificial Intelligence and Cancer Clinical Research: III Risk Prediction Models for Febrile Neutropenia in Patients Receiving Cancer Chemotherapy

  2024cites this paper
• Adjuvant Properties of Caffeic Acid in Cancer Treatment

  2024cites this paper
• Misdiagnosis of severe and atypical oxaliplatin‑related hypersensitivity reaction following chemotherapy combined with PD‑1 inhibitor: A case report and literature review

  2024cites this paper
• Effective Prevention and Treatment of Acute Leukemias in Mice by Activation of Thermogenic Adipose Tissues

  2024cites this paper
• An ultra-long-acting L-asparaginase synergizes with an immune checkpoint inhibitor in starvation-immunotherapy of metastatic solid tumors.

  2024cites this paper
• Current advance of nanotechnology in diagnosis and treatment for malignant tumors

  2024cites this paper
• Impact of Hyponatremia on COVID-19-Related Outcomes: A Retrospective Analysis

  2024cites this paper
• Conversation between host and gut microbiota unveils a "silver bullet" therapeutic option for chemotherapy.

  2024cites this paper
• Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

  2024cites this paper
• The Importance of Nutrition in Cancer Care: A Narrative Review

  2024cites this paper
• Tumor Micro-Environment Interactions Guided Graph Learning for Survival Analysis of Human Cancers from Whole-Slide Pathological Images

  2024cites this paper
• Beyond aromatherapy: can essential oil loaded nanocarriers revolutionize cancer treatment?

  2024cites this paper
• Penetration enhancers strengthen tough hydrogel bioadhesion and modulate locoregional drug delivery.

  2024cites this paper
• Case report: dynamic personalized physiological monitoring in lung cancer using wearable data

  2024cites this paper
• Immune-related and Common Adverse Events With Programmed Cell Death 1/Programmed Cell Death Ligand 1 inhibitors combined with other Anticancer Therapy for Solid Tumors: A Systematic Review and Meta-analysis.

  2024cites this paper
• Potential Anti-tumor Effects and Apoptosis-Inducing Mechanisms of Saponins: A Review.

  2024cites this paper
• The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development.

  2024cites this paper